Drug survival of secukinumab for psoriasis in a real-world setting

被引：15
|
作者：
Lee, Erica B. [1 ]
Amin, Mina [2 ]
Egeberg, Alexander [3 ]
Wu, Jashin J. [4 ]
机构：
[1] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[2] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA
[3] Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
[4] Kaiser Permanente, Los Angeles Med Ctr, Dept Dermatol, Los Angeles, CA 90027 USA
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2019年 / 30卷 / 02期
关键词：
EFFICACY;
D O I：
10.1080/09546634.2018.1473838
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [1] Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
    Iznardo, H.
    Vilarrasa, E.
    Lopez-Ferrer, A.
    Puig, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : 660 - 662
  • [2] DRUG SURVIVAL OF SECUKINUMAB FOR PSORIATIC ARTHRITIS IN A REAL-WORLD SETTING
    Valero, Marta
    Joven-Ibanez, Beatriz
    Martin, Maria
    Campos Esteban, Jose
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Perez Gomez, Ana
    Bachiller-Corral, Javier
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1862 - 1862
  • [3] Comment on "Drug survival of apremilast for psoriasis in a real-world setting"
    Santos-Juanes, Jorge
    Velasco, Lucia
    Munguia-Calzada, Pablo
    Lozano, Ana
    Gomez-Diez, Santiago
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : E83 - E84
  • [4] Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study
    Torres, Tiago
    Balato, Anna
    Conrad, Curdin
    Conti, Andrea
    Dapavo, Paolo
    Ferreira, Paulo
    Gaiani, Francesca
    Leite, Luiz
    Malagoli, Piergiorgio
    Mendes-Bastos, Pedro
    Megna, Matteo
    Messina, Francesco
    Nidegger, Alessia
    Odorici, Giulia
    Piaserico, Stefano
    Prignano, Francesca
    Ribero, Simone
    Ricceri, Federica
    Tonini, Annalisa
    Valerio, Joana
    Chiricozzi, Andrea
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) : 273 - 275
  • [5] SECUKINUMAB FOR AXIAL SPONDYLOARTHRITIS: DRUG SURVIVAL IN REAL-WORLD SETTING AND RESPONSE FACTORS
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Martin, Maria
    Valero, Marta
    Bachiller-Corral, Javier
    Joven-Ibanez, Beatriz
    Perez Gomez, Ana
    Campos Esteban, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 887 - 887
  • [6] Real-world NHS drug survival and efficacy data for Secukinumab in chronic plaque psoriasis
    Goon, P. K. C.
    Banfield, C. C.
    Bello, O.
    Abraham, T.
    Lim, H. Y.
    Summerfield, E.
    Shalders, K.
    Sudhoff, H.
    Mallett, R. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (11) : E716 - E718
  • [7] Comment on "Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study''
    Palacios-Garcia, Laura
    Gomez-de Castro, Celia
    Mir-Bonafe, Marc
    Calzon, Cristina
    Galache, Cristina
    Santos-Juanes, Jorge
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (03) : E81 - E82
  • [8] Repy to: "Comment on 'Drug survival of apremilast for psoriasis in a real-world setting'"
    Lee, Erica B.
    Amin, Mina
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : E85 - E85
  • [9] Drug survival of apremilast in patients treated for psoriasis in a real-world setting
    Lee, Erica B.
    Amin, Mina
    Wu, Jashin J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (04) : 760 - 761
  • [10] Drug Survival of Secukinumab for Axial Spondyloarthritis in a Real-World Setting Possible Response Factors
    Merino Argumanez, Carolina
    Emperiale, Valentina
    Martin, Maria
    Valero, Marta
    Bachiller, Javier
    Joven-Ibanez, Beatriz
    Perez-Gomez, Ana
    Campos, Jose
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345